GeneNews Announces Election of Directors

GeneNews Announces Election of Directors

TORONTO, May 30, 2013 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN)
("GeneNews" or the "Company") announces that the nominees listed in the
management information circular for the annual and special meeting (the
"Meeting") of shareholders held on Tuesday, May 28, 2013 were elected as
directors of GeneNews.

Detailed results of the vote for the election of directors are set out below.

Nominees           Votes FOR  % FOR Votes WITHHELD % WITHHELD
Heiner Dreismann   13,382,089 99.48 69,432         0.52
Gailina Liew       13,382,089 99.48 69,432         0.52
Rory Riggs         13,382,089 99.48 69,432         0.52
Garth MacRae       13,382,089 99.48 69,432         0.52
David Sable        13,382,089 99.48 69,432         0.52
Harry Glorikian    13,382,089 99.48 69,432         0.52
James Howard-Tripp 13,382,089 99.48 69,432         0.52

About GeneNews

GeneNews is a molecular diagnostics company focused on developing and
commercializing proprietary blood-based diagnostic tests through the
application of functional genomics to enable early diagnosis and personalized
health management. The Company has developed a patented core platform
technology, the Sentinel Principle^®, which has the power to detect and stage
virtually any disease or medical condition from a simple blood sample.
GeneNews has applied the Sentinel Principle^® in major areas with unmet
clinical needs such as cancer, arthritis, cardiovascular disease and
neurological disorders. GeneNews' lead product, ColonSentry^®, is the world's
first blood test to assess an individual's current risk for colorectal cancer.
For more information on GeneNews and ColonSentry^®, go to www.GeneNews.com or
www.ColonSentry.com.

Forward-Looking Statements

This press release contains forward-looking statements, which reflect the
Company's current expectations regarding future events. The forward-looking
statements involve risks and uncertainties. Actual events could differ
materially from those projected herein. Investors should consult the Company's
ongoing quarterly filings and annual reports for additional information on
risks and uncertainties relating to these forward-looking statements. The
reader is cautioned not to rely on these forward-looking statements. The
Company disclaims any obligation to update these forward-looking statements.

CONTACT: Company Contact:
         Gailina Liew
         President & COO
         Office: (905) 739-2036
         Mobile: (416) 844-0649
         gliew@genenews.com
        
         Investor & Media Contact:
         Stephen Kilmer
         Kilmer Lucas Inc.
         Office: (212) 618-6347
         Mobile: (905) 906-6908
         stephen@kilmerlucas.com
 
Press spacebar to pause and continue. Press esc to stop.